Sofinnova'speople
Individual strengths, united purpose
We embrace individual uniqueness and diversity, while our greatest strength is in our unity and common purpose.
Antoine Papiernik
Chairman & Managing Partner
Henrijette Richter
Managing Partner
Monique Saulnier
Managing Partner & COO
Graziano Seghezzi
Managing Partner
Joe Anderson
Partner, Crossover Strategy
Guillaume Baxter
Principal, Industrial Biotech Strategy
Anna Belousova
Analyst, Industrial Biotech Strategy
Maina Bhaman
Partner, Capital Strategy
Joško Bobanović
Partner, Industrial Biotech Strategy
Tom Burt
Partner, Crossover Strategy
Claire Catherinet
Associate, Crossover Strategy
Anouck Champsaur
Associate, Industrial Biotech Strategy
Cécile Dupont
Principal, Program Director, MD Start Strategy
Marie Duranteau
Senior Analyst, Capital Strategy
Lucia Faccio
Partner, Sofinnova Telethon Strategy
Marion Gasperment
Associate, Program Manager, MD Start Strategy
Anta Gkelou
Principal, Capital Strategy
Lukas Guenther
Partner, MD Start Strategy
Kuang He
Associate, Crossover Strategy
Kinam Hong
Partner, Crossover Strategy
Ankeet Jethwa
Associate, Capital Strategy
Edward Kliphuis
Partner
Michael Krel
Partner, Industrial Biotech Strategy
Denis Lucquin
Partner & Senior Advisor, Industrial Biotech Strategy
Cedric Moreau
Partner, Crossover Strategy
Anne Osdoit
Partner, MD Start Strategy
Paola Pozzi
Partner, Sofinnova Telethon Strategy
Tiziana Rossetti
Senior Associate, Sofinnova Telethon Strategy
Jacques Theurillat
Partner, Crossover Strategy
Simon Turner
Partner
ZhiZhong (Joel) Yao
Principal, Capital Strategy
Malty Ba
Reporting Officer
Thomas Bermudes
Senior Legal Counsel
Christophe Blanche
Chief Financial Officer
Armance Bordes
General Counsel
Robert Carroll
Partner, Head of Investor Relations, ESG and Impact
Gabriel Challot
Communications Designer
Laura Daudin-Antoine
Legal Counsel
Bertrand Echalard
Management Company Accounting
Juliette Grant
Executive Assistant
Johanna Guacide
Funds Accounting
Stéphanie Huiban
Head of Information Systems
Sarah Lafaye
Investor Reporting
Marc Lahoudie
IT Support
Sandrine Le Penru
Executive Assistant
Aziliz Le Roux
Investor Relations and Reporting Officer
Bommy Lee
Head of Communications
Delphine Linard
Executive Assistant
Nathalie Loreaux
Investor Relations and Reporting Manager
Caroline Patard
Administrative and financial manager
Paola Pizzi
Head of Operations, Italy
Ashvin Rajee
Paralegal
Estelle Rigaux
Compliance Officer
Annie Tréhard
Management Company Accounting
Géraldine Usseglio
Head of Human Resources
Dominique Verdier
Reception and Administration
Lamia Verney
Executive Assistant
Gabriella Camboni
Venture Partner
Luigi Costa
Entrepreneur in Residence
Gérard Hascoët
Venture Partner
Gonzague Issenmann
Entrepreneur in Residence
Silvano Spinelli
Venture Partner
Martin T. Rothman
Venture Partner
Articles about the team
CinCor Pharma announces positive topline data for Phase 2 BrigHtn trial evaluating baxdrostat, its selective aldosterone synthase inhibitor, in treatment-resistant hypertension
F2G announces $70 million financing to advance development and commercialization of new antifungal agent olorofim
Noema Pharma announces recruitment of first patient in Orpheus Phase 2b Study of PDE10A inhibitor gemlapodect in adults with childhood onset fluency disorder
CinCor Pharma announces last patient randomized in Phase 2 HALO Trial and initiation of long-term extension study for Baxdrostat, a selective aldosterone synthase inhibitor, in uncontrolled hypertension
ReCor Medical and Otsuka Medical Devices announce primary endpoint met in the RADIANCE II U.S. pivotal trial of the Paradise™ System for the treatment of hypertension